The latest biotech news

News and Trends 20 Aug 2014

uniQure acquires the gene therapy start-up InoCard

uniQure, a leader in human gene therapy, today announced the acquisition of InoCard GmbH, an innovative, early-stage biotechnology company focused on the development of gene therapy approaches for cardiac disease. InoCard has developed a novel gene therapy to preclinical proof of concept, for the one-time treatment of congestive heart failure (CHF), a rapidly progressing disease […]

August 20, 2014 - 3 minutesmins - By Joachim Eeckhout

News and Trends 19 Aug 2014

Ablynx gain €2.1m to develop a novel Nanobodies for Ocular applications

Ablynx is a biopharmaceutical company engaged in the discovery and development of Nanobodies, a novel class of therapeutic proteins based on single-domain antibody fragments, for a range of serious human diseases, including inflammation, haematology, oncology and pulmonary disease. Ablynx today announced that it has been awarded a €2.1 million grant by the Flemish Agency for […]

August 19, 2014 - 2 minutesmins - By Joachim Eeckhout

News and Trends 19 Aug 2014

GSK abandon its joint drug project with Galapagos

According to Reuters, Galapagos, a Belgian biotech group announced that GlaxoSmithKline has stopped a joint drug development project over concerns about adverse effects. In June 2006, Galapagos signed a broad alliance with GSK to discover and develop breakthrough medicines. This multi-target, multi-year alliance runs from target discovery through to delivery of a clinical Proof of Concept. […]

August 19, 2014 - 2 minutesmins - By Joachim Eeckhout

News and Trends 19 Aug 2014

Sanofi buy Mannkind’s inhaled insulin for $925m

Sanofi and MannKind Corporation announced today that they have entered into a worldwide exclusive licensing agreement for development and commercialization of Afrezza (insulin human) Inhalation Powder, a new rapid-acting inhaled insulin therapy for adults with type 1 and type 2 diabetes. The companies plan to launch Afrezza in the United States in the first quarter […]

August 19, 2014 - 3 minutesmins - By Joachim Eeckhout

News and Trends 19 Aug 2014

ProQR Therapeutics files for a $75m IPO to compete with Vertex Pharmaceuticals

ProQR Therapeutics is a Netherlands-based biotech company focused on developments of drugs to treat genetic disorders. Daniel de Boer, Gerard Platenburg, Dinko Valerio and Henri Termeer (former Genzyme’s CEO) founded the company in May 2012 with the main goal of finding a treatment for cystic fibrosis. ProQR has now expanded to more than 50 employees who are working […]

August 19, 2014 - 3 minutesmins - By Joachim Eeckhout

News and Trends 15 Aug 2014

Active Biotech and Teva together in a Phase II clinical trial against Huntington’s disease

Active Biotech announced today that its partner Teva Pharmaceutical will initiate a phase II clinical trial to evaluate the efficacy and safety of oral laquinimod for the treatment of Huntington’s disease. Laquinimod is a once-daily oral, investigational, CNS-active immunomodulator with a novel mechanism of action being developed primarily for the treatment of relapsing-remitting multiple sclerosis […]

August 15, 2014 - 1 minutemin - By Joachim Eeckhout

News and Trends 15 Jul 2014

Relive BIO 2014, the World’s Biggest Biotech Convention

Relive BIO 2014 exhibition was held from the June 23rd to June 26th in San Diego, California and I was lucky to go there. 15667 other people, including 2,500 CEOs from more than 50 different countries came too. Why this event fascinates? Why major biotech actors in the world are meeting there every year? I will try to answer these […]

July 15, 2014 - 5 minutesmins - By Philip Hemme

News and Trends 19 May 2014

Discover Hello Tomorrow Challenge, European largest technological start-up challenge

I was lucky to be invited as a media partner for the first edition of Hello Tomorrow Challenge (HTC) on April 18 at the Museum of Science and Industry in Paris. Technological innovations of the future were highlighted and rewarded by over 400k€. The event gathered over 1,200 attendees and focused on five major areas that […]

May 19, 2014 - 3 minutesmins - By Philip Hemme

Knowledge hub

Categories

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Approaches

Therapeutic areas

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

These 7 biotechs are shaping the next generation of endometriosis care

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

News and Trends

uniQure acquires the gene therapy start-up InoCard

Ablynx gain €2.1m to develop a novel Nanobodies for Ocular applications

GSK abandon its joint drug project with Galapagos

Sanofi buy Mannkind’s inhaled insulin for $925m

ProQR Therapeutics files for a $75m IPO to compete with Vertex Pharmaceuticals

Active Biotech and Teva together in a Phase II clinical trial against Huntington’s disease

Relive BIO 2014, the World’s Biggest Biotech Convention

Discover Hello Tomorrow Challenge, European largest technological start-up challenge

Subscribe to our newsletter to get the latest biotech news!

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!